Share Twitter LinkedIn Facebook Email Stephen Hunger, MD from Children’s Hospital of Philadelphia discusses EsPhALL regimen and adding Dasatnib to intensive chemotherapy backbone at the 2017 American Society of Hematology. Advertisement
Advancing Acute Lymphoblastic Leukemia Treatment with CAR-T Cells: Insights from Dr. Anjali Advani Acute Lymphoblastic Leukemia 3 Mins Read
Advances in Acute Lymphoblastic Leukemia (ALL) Treatment: A Focus on Targeted Therapies – Elias Jabbour, MD Acute Lymphoblastic Leukemia 4 Mins Read